Jeena Sikho Lifecare Holds 9th AGM: Approves Financials & Dividend
Jeena Sikho Lifecare's 9th AGM on Sep 28, 2026, approved FY26 financials and a ₹4.50 dividend. Key re-appointments include Manish Grover as MD and Bhavna Grover as Whole-time Director. New directors Ajay Sharma, Sapna Singh, Dr. Ish Sharma, and Ankush Kaushal were also appointed. Approvals were given for loans and investments under Sections 185 and 186.
The approval of financial statements and dividend declaration are positive for shareholders. The appointment of new directors and re-appointment of existing ones signifies potential strategic shifts or strengthening of the management team, which could have a medium-term impact on the company's operations and governance.
The announcement details the successful conclusion of the Annual General Meeting with overwhelming support for all resolutions, including financial statement adoption and dividend declaration. The re-appointment and appointment of key management and directors further indicate stability and forward momentum.
Jeena Sikho Lifecare Limited announced the outcome of its 9th Annual General Meeting (AGM) held on Monday, 28th September 2026, at 12:00 Noon IST. The meeting was convened at First Floor, Parle G Godown, City Enclave, Back Side JP Hospital, Near Anand Complex, Zirakpur Main Road, SAS Nagar, Punjab – 140603.
The company submitted the combined voting results and the consolidated scrutinizer's report dated 29th September 2026, in accordance with SEBI Listing Regulations and the Companies Act, 2013. The voting results indicated overwhelming support for all resolutions.
Key resolutions passed include the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended 31st March 2026. Additionally, a final dividend of ₹4.50 per equity share of face value ₹2 each for the financial year ended March 31, 2026, was declared.
The AGM also saw the re-appointment of key management personnel and directors. Mrs. Bhavna Grover was re-appointed as Director and Whole-time Director & Key Managerial Personnel. Mr. Manish Grover was re-appointed as Managing Director & Key Managerial Personnel. Mr. Karan Vir Bindra was re-appointed as an Independent Director. Mr. Ajay Sharma and Mrs. Sapna Singh were appointed as Non-Executive Independent Directors. Dr. Ish Sharma was appointed as a Director and Whole-Time Director & Key Managerial Personnel. Mr. Ankush Kaushal was appointed as a Director and Whole-Time Director & Key Managerial Personnel.
Furthermore, approvals were granted for granting loans, guarantees, or securities, and for making investments under Sections 185 and 186 of the Companies Act, 2013.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.